Browsing: biopharma nl

Tempus AI, a company that brings artificial intelligence to diagnostics, is growing its capabilities in oncology through a $1.5 billion…

Statins are a standard drug for managing high cholesterol, but for patients who need something stronger, a newer class of…

There are no FDA-approved treatments for recurrent chronic cough, and a GSK drug from a $2 billion acquisition just lost…

Advanced cases of breast cancer now have a new FDA-approved treatment option, a Celcuity drug whose first-in-a class approach could…

On April 28, the FDA announced the successful initiation of two real-time clinical trials and released a Request for Information…

GSK has results from a pivotal clinical trial showing rectal cancer patients treated with its drug avoided the need for…

The cyberattack on Novo Nordisk has become much more than another healthcare data breach. What began as unauthorized access appears…

AstraZeneca’s newest addition to its respiratory pipeline is an inhalable medication that could rival a Merck drug approved for treating…

Bausch + Lomb is dropping plans to develop a drug for glaucoma after the experimental treatment failed a mid-stage clinical…

An RNA therapy from partners Ionis Pharmaceuticals and AstraZeneca failed a pivotal study as a treatment for a type of…